Notably, CD133+ CSCs in glioblastoma promote tumor angiogenesis by secreting pro-angiogenic factors such as VEGF and stromal-derived factor-1 (SDF-1), attracting EPCs to the tumor site [241]. This evidence concerns the gene CXCL12 and glioblastoma.